WNT3A and colorectal carcinoma: c-MYC is a master regulator of the Wnt signaling pathway, which is a key driver in the development of CRC.56 Thus, we assessed whether the effect of SMYD3 pharmacological inhibition could be reversed by Wnt3a-induced exogenous activation of the Wnt pathway.